Depression and BMI influences the serum vascular endothelial growth factor level

Betina Elfving; Henriette Nørmølle Buttenschøn; Leslie Foldager; Pia H P Poulsen; Matias Brødsgaard Grynderup; Åse Marie Hansen; Henrik A. Kolstad; Linda Kaerlev; Sigurd Mikkelsen; Anders Børglum; Gregers Wegener; Ole Mors

doi:10.1017/s1461145714000273

Depression and BMI influences the serum vascular endothelial growth factor level

Betina Elfving, Henriette Nørmølle Buttenschøn, Leslie Foldager, Pia H P Poulsen, Matias Brødsgaard Grynderup, Åse Marie Hansen, Henrik A. Kolstad, Linda Kaerlev, Sigurd Mikkelsen, Anders Børglum, Gregers Wegener, Ole Mors

Section of Social Medicine

28 Citations (Scopus)

Abstract

Recent studies suggest that the angiogenic cytokine vascular endothelial growth factor (VEGF) is involved in the pathogenesis of depression. However, only a few studies have investigated serum VEGF levels in individuals with depression, or the possible association between genetic variants within the VEGF gene and depression. The purpose of the present study was to investigate differences between serum VEGF levels in individuals with depression vs. control individuals, and associations between genetic markers located within VEGF and depression. In addition, determinants of the serum VEGF levels were identified. One-hundred and fifty-five depressed subjects and 280 controls were included in the study. All individuals returned a questionnaire and participated in a semi-structured diagnostic interview. Eleven single nucleotide polymorphisms were successfully analysed. VEGF levels were measured in serum by immunoassay and independent determinants of the serum VEGF level were assessed by generalized linear models.The main findings were that depression, severity of depression, previous depressive episodes, age and body mass index (BMI) were associated with higher serum VEGF levels. The genetic marker rs10434 was significantly associated with depression after correction for multiple testing, but not with the serum VEGF level. Our final model included depression and BMI as predictors of serum VEGF levels. Our study suggests a role for circulating serum VEGF in depression. Furthermore, our data also demonstrate that other factors than a diagnosis of depression influence the serum VEGF level. The importance of these factors should be emphasized when studies are compared.

Original language	English
Journal	International Journal of Neuropsychopharmacology
Volume	17
Issue number	9
Pages (from-to)	1409-1417
Number of pages	9
ISSN	1461-1457
DOIs	https://doi.org/10.1017/s1461145714000273
Publication status	Published - 1 Sept 2014

Access to Document

10.1017/s1461145714000273

Cite this

Elfving, B., Buttenschøn, H. N., Foldager, L., Poulsen, P. H. P., Grynderup, M. B., Hansen, Å. M., Kolstad, H. A., Kaerlev, L., Mikkelsen, S., Børglum, A., Wegener, G., & Mors, O. (2014). Depression and BMI influences the serum vascular endothelial growth factor level. International Journal of Neuropsychopharmacology, 17(9), 1409-1417. https://doi.org/10.1017/s1461145714000273

Elfving, B, Buttenschøn, HN, Foldager, L, Poulsen, PHP, Grynderup, MB, Hansen, ÅM, Kolstad, HA, Kaerlev, L, Mikkelsen, S, Børglum, A, Wegener, G & Mors, O 2014, 'Depression and BMI influences the serum vascular endothelial growth factor level', International Journal of Neuropsychopharmacology, vol. 17, no. 9, pp. 1409-1417. https://doi.org/10.1017/s1461145714000273

@article{b83acb912be34a1e935600e87aa50d8b,

title = "Depression and BMI influences the serum vascular endothelial growth factor level",

abstract = "Recent studies suggest that the angiogenic cytokine vascular endothelial growth factor (VEGF) is involved in the pathogenesis of depression. However, only a few studies have investigated serum VEGF levels in individuals with depression, or the possible association between genetic variants within the VEGF gene and depression. The purpose of the present study was to investigate differences between serum VEGF levels in individuals with depression vs. control individuals, and associations between genetic markers located within VEGF and depression. In addition, determinants of the serum VEGF levels were identified. One-hundred and fifty-five depressed subjects and 280 controls were included in the study. All individuals returned a questionnaire and participated in a semi-structured diagnostic interview. Eleven single nucleotide polymorphisms were successfully analysed. VEGF levels were measured in serum by immunoassay and independent determinants of the serum VEGF level were assessed by generalized linear models.The main findings were that depression, severity of depression, previous depressive episodes, age and body mass index (BMI) were associated with higher serum VEGF levels. The genetic marker rs10434 was significantly associated with depression after correction for multiple testing, but not with the serum VEGF level. Our final model included depression and BMI as predictors of serum VEGF levels. Our study suggests a role for circulating serum VEGF in depression. Furthermore, our data also demonstrate that other factors than a diagnosis of depression influence the serum VEGF level. The importance of these factors should be emphasized when studies are compared.",

author = "Betina Elfving and Buttensch{\o}n, {Henriette N{\o}rm{\o}lle} and Leslie Foldager and Poulsen, {Pia H P} and Grynderup, {Matias Br{\o}dsgaard} and Hansen, {{\AA}se Marie} and Kolstad, {Henrik A.} and Linda Kaerlev and Sigurd Mikkelsen and Anders B{\o}rglum and Gregers Wegener and Ole Mors",

year = "2014",

month = sep,

day = "1",

doi = "10.1017/s1461145714000273",

language = "English",

volume = "17",

pages = "1409--1417",

journal = "International Journal of Neuropsychopharmacology",

issn = "1461-1457",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Depression and BMI influences the serum vascular endothelial growth factor level

AU - Elfving, Betina

AU - Buttenschøn, Henriette Nørmølle

AU - Foldager, Leslie

AU - Poulsen, Pia H P

AU - Grynderup, Matias Brødsgaard

AU - Hansen, Åse Marie

AU - Kolstad, Henrik A.

AU - Kaerlev, Linda

AU - Mikkelsen, Sigurd

AU - Børglum, Anders

AU - Wegener, Gregers

AU - Mors, Ole

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Recent studies suggest that the angiogenic cytokine vascular endothelial growth factor (VEGF) is involved in the pathogenesis of depression. However, only a few studies have investigated serum VEGF levels in individuals with depression, or the possible association between genetic variants within the VEGF gene and depression. The purpose of the present study was to investigate differences between serum VEGF levels in individuals with depression vs. control individuals, and associations between genetic markers located within VEGF and depression. In addition, determinants of the serum VEGF levels were identified. One-hundred and fifty-five depressed subjects and 280 controls were included in the study. All individuals returned a questionnaire and participated in a semi-structured diagnostic interview. Eleven single nucleotide polymorphisms were successfully analysed. VEGF levels were measured in serum by immunoassay and independent determinants of the serum VEGF level were assessed by generalized linear models.The main findings were that depression, severity of depression, previous depressive episodes, age and body mass index (BMI) were associated with higher serum VEGF levels. The genetic marker rs10434 was significantly associated with depression after correction for multiple testing, but not with the serum VEGF level. Our final model included depression and BMI as predictors of serum VEGF levels. Our study suggests a role for circulating serum VEGF in depression. Furthermore, our data also demonstrate that other factors than a diagnosis of depression influence the serum VEGF level. The importance of these factors should be emphasized when studies are compared.

AB - Recent studies suggest that the angiogenic cytokine vascular endothelial growth factor (VEGF) is involved in the pathogenesis of depression. However, only a few studies have investigated serum VEGF levels in individuals with depression, or the possible association between genetic variants within the VEGF gene and depression. The purpose of the present study was to investigate differences between serum VEGF levels in individuals with depression vs. control individuals, and associations between genetic markers located within VEGF and depression. In addition, determinants of the serum VEGF levels were identified. One-hundred and fifty-five depressed subjects and 280 controls were included in the study. All individuals returned a questionnaire and participated in a semi-structured diagnostic interview. Eleven single nucleotide polymorphisms were successfully analysed. VEGF levels were measured in serum by immunoassay and independent determinants of the serum VEGF level were assessed by generalized linear models.The main findings were that depression, severity of depression, previous depressive episodes, age and body mass index (BMI) were associated with higher serum VEGF levels. The genetic marker rs10434 was significantly associated with depression after correction for multiple testing, but not with the serum VEGF level. Our final model included depression and BMI as predictors of serum VEGF levels. Our study suggests a role for circulating serum VEGF in depression. Furthermore, our data also demonstrate that other factors than a diagnosis of depression influence the serum VEGF level. The importance of these factors should be emphasized when studies are compared.

U2 - 10.1017/s1461145714000273

DO - 10.1017/s1461145714000273

M3 - Journal article

C2 - 24636631

SN - 1461-1457

VL - 17

SP - 1409

EP - 1417

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

IS - 9

ER -

Depression and BMI influences the serum vascular endothelial growth factor level

Abstract

Access to Document

Fingerprint

Cite this